- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01826695
Neurodynamic Intervention in Fibromyalgia (FM)
Study of the Effectiveness of a Neurodynamic Intervention in Women With Fibromyalgia.
Fibromyalgia is a chronic illness characterised by persistent,widespread muscle pain with generalised hyperalgesia and allodynia. It can be accompanied by other concomitant symptoms like fatigue, sleep disturbances, musculoskeletal disorders, distress and psychological disorders. This condition is very prevalent. It has been reported to be about 2-5% of the general global population.
Fibromyalgia have been reported to have neurodynamic disorders. The purpose of this prospective study was to examine the combined effects of soft tissue mobilization and nerve slider neurodynamic technique on pain and pressure sensitivity in women with fibromyalgia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fibromyalgia affects women nine times more than men.The pathophysiology of fibromyalgia is being studied nowadays in order to understand the mechanisms implicated in it.
The treatment propose in this study is a neurodynamic intervention. Neurodynamics is the term used to describe the integration of the morphology, biomechanics and physiology of the nervous system.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Granada
-
Granada., Granada, Spain, 18071
- Faculty of Health Sciences. University of Granada.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women diagnosed with Fibromyalgia attending to the Fibromyalgia Association of Granada.
- Women who can complete the assessment battery of tests at the beginning and at the end of the study
- Female sex.
Exclusion Criteria:
- Male sex.
- Auditive and visual disturbances.
- Cognitive problems.
- Psychiatric pathology.
- Traumatic pathology of the hand.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo group
35 women are recruited in order to the inclusion criteria for the study.
Placebo controlled.
They received only standard treatment without neurodynamic intervention.
They are diagnosed with Fibromyalgia attending to the Fibromyalgia Association of Granada.
The study include subjects who can complete the assessment battery of tests at the beginning and end.
|
Women in this group realized standard treatment in the Fibromyalgia Association without neurodynamic techniques.
Other Names:
|
|
Active Comparator: Neurodynamic technique group
35 women are recruited, diagnosed with Fibromyalgia attending to the Fibromyalgia Association of Granada.
The study include subjects who can complete the assessment battery of tests at the beginning and at the end.
|
Neurodynamic techniques are used in order to move most of the nerves between the neck and hand, including the median nerve, radial and ulnar, brachial plexus, spinal nerves and cervical nerve roots. The patient is placed supine position. The treatment will be carry out 3 times per week during 8 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nervous assessment
Time Frame: baseline, 8 weeks
|
Changes from baseline to postintervention measured with neurodynamic tests This is to test upper extremities. It moves most of the nerves between the neck and hand, including the median nerve, radial and ulnar, brachial plexus, spinal nerves and cervical nerve roots. The patient is placed supine position. It is measured with a goniometer. |
baseline, 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manual dexterity
Time Frame: baseline, 8 weeks
|
Changes from baseline to postintervention in dexterity. This is assessed using the Purdue Pegboard Test. The Purdue pegboard test is a timed physical test used to measure manual dexterity. Test subjects are asked to place small pins into holes in the pegboard using a specific hand and following a specific process. |
baseline, 8 weeks
|
|
Grip strength
Time Frame: baseline, 8 weeks
|
Changes from baseline to postintervention in grip strength. This is measured using a Jamar dynamometer with a standard protocol allowing three attempts on each side. During each measurement, patients were sitting with their shoulder adducted and elbow flexed to 90°. The maximum value achieved from all six attempts was used in analyses. Kg/cm2 |
baseline, 8 weeks
|
|
Pressure pain measure
Time Frame: baseline, 8 weeks
|
Changes in pain pressure threshold from baseline to 8-weeks intervention.
This is going to be measured in three points in upper extremities using the pressure algometer.
All assessments were made by the same investigator.
All the subjects were trained to familiarize the subjects with the pressure algometry procedure before the measures in an anatomical site different from the chosen sites for this study.
|
baseline, 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety and depression
Time Frame: baseline, 8 weeks
|
Changes from baseline to postintervention in anxiety and depression in the participants.
Participants completed the Hospital Anxiety and Depression Scale in order to assess these parameters.
|
baseline, 8 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DF0040UG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.